Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

Health, Risk and News: the MMR vaccine and the media

A vaccine vial stands before abstract newspaper layouts in a muted editorial illustration.

Health, Risk and News: the MMR vaccine and the media is a Reuters Institute for the Study of Journalism event with Dr. Tammy Boyce, Research Fellow in Risk, Health and Science Communication and Deputy Director of the Risk, Science and Health Group, Cardiff School of Journalism, Media and Cultural Studies. This Professional Development event takes place on 13 February 2008 in the Committee Room, Green College.

Hosted with: Psychedelic Writers Guild